PANCE Domain 7: Hematologic System (5%) - Complete Study Guide 2027

PANCE Domain 7 Overview: Hematologic System

The Hematologic System represents 5% of the PANCE examination, translating to approximately 15 questions out of the 300 total multiple-choice questions. While this may seem like a smaller domain compared to the Cardiovascular System domain at 11%, mastering hematology is crucial for achieving a passing score of 350 on the 200-800 scale.

The hematologic system encompasses disorders affecting blood cells, bone marrow, lymph nodes, and coagulation mechanisms. This domain integrates closely with other systems, particularly infectious diseases and neurologic conditions, making comprehensive understanding essential for success.

Key Hematologic System Topics

Domain 7 covers a comprehensive range of hematologic conditions that physician assistants encounter in clinical practice. Understanding the scope and depth of these topics is essential for effective preparation. According to the complete guide to all 15 content areas, this domain requires both foundational knowledge and clinical application skills.

Primary Topic Categories

Category	Key Conditions	Weight
Anemias	Iron deficiency, B12/folate deficiency, hemolytic, aplastic	High
Coagulation Disorders	DVT, PE, bleeding disorders, anticoagulation	High
Hematologic Malignancies	Leukemias, lymphomas, multiple myeloma	Medium
White Blood Cell Disorders	Neutropenia, leukocytosis, immunodeficiencies	Medium
Platelet Disorders	Thrombocytopenia, ITP, TTP	Medium

Each category requires understanding of pathophysiology, diagnostic approaches, treatment options, and potential complications. The NCCPA emphasizes clinical scenarios that test your ability to interpret laboratory results within the context of patient presentations.

Anemias and Red Blood Cell Disorders

Anemia represents one of the most frequently tested topics within Domain 7. Understanding the classification system and diagnostic approach is fundamental to success on the PANCE examination.

Classification by MCV (Mean Corpuscular Volume)

Microcytic Anemia (MCV < 80 fL):

• Iron Deficiency Anemia: Most common cause worldwide, characterized by low ferritin, high TIBC, and low iron saturation
• Thalassemia: Genetic disorder with elevated HbA2 or HbF, target cells on peripheral smear
• Anemia of Chronic Disease: Normal to elevated ferritin, low TIBC, chronic inflammatory conditions
• Sideroblastic Anemia: Ring sideroblasts on bone marrow examination, elevated iron stores

Normocytic Anemia (MCV 80-100 fL):

• Acute Blood Loss: History of trauma, surgery, or GI bleeding
• Chronic Kidney Disease: Decreased erythropoietin production
• Bone Marrow Disorders: Aplastic anemia, myelofibrosis, malignancy infiltration
• Hemolytic Anemia: Elevated LDH, decreased haptoglobin, elevated indirect bilirubin

Macrocytic Anemia (MCV > 100 fL):

• Megaloblastic: B12 or folate deficiency, hypersegmented neutrophils
• Non-megaloblastic: Alcohol use, liver disease, hypothyroidism, reticulocytosis

Hemolytic Anemias

Hemolytic anemias require understanding of both intravascular and extravascular hemolysis mechanisms:

Intravascular Hemolysis:

• Hemoglobinuria and hemoglobinemia present
• Causes: PNH, mechanical heart valves, microangiopathic conditions
• Laboratory findings: Markedly decreased haptoglobin, hemoglobinuria

Extravascular Hemolysis:

• Occurs in spleen and liver
• Causes: Hereditary spherocytosis, G6PD deficiency, autoimmune hemolytic anemia
• Laboratory findings: Spherocytes, positive Coombs test (when autoimmune)

Bleeding and Coagulation Disorders

Coagulation disorders represent a high-yield topic area within Domain 7, encompassing both bleeding disorders and thrombotic conditions. Understanding the coagulation cascade and interpreting coagulation studies is essential for PANCE success.

Coagulation Cascade Overview

The coagulation system involves intrinsic, extrinsic, and common pathways:

• PT/INR: Monitors extrinsic pathway (Factor VII) and common pathway
• aPTT: Monitors intrinsic pathway (Factors VIII, IX, XI, XII) and common pathway
• Thrombin Time: Measures conversion of fibrinogen to fibrin
• Bleeding Time/PFA-100: Assesses platelet function

Inherited Bleeding Disorders

Hemophilia A (Factor VIII Deficiency):

• X-linked recessive inheritance
• Prolonged aPTT, normal PT
• Deep tissue and joint bleeding (hemarthroses)
• Treatment: Factor VIII concentrates, desmopressin for mild cases

Hemophilia B (Factor IX Deficiency):

• X-linked recessive inheritance
• Clinically identical to Hemophilia A
• Treatment: Factor IX concentrates

Von Willebrand Disease:

• Most common inherited bleeding disorder
• Mucocutaneous bleeding pattern
• Prolonged bleeding time, may have prolonged aPTT
• Treatment: Desmopressin, von Willebrand factor concentrates

Acquired Bleeding Disorders

Vitamin K Deficiency:

• Affects Factors II, VII, IX, X, Proteins C and S
• Prolonged PT initially, then aPTT
• Causes: Malabsorption, antibiotic use, liver disease

Liver Disease:

• Decreased synthesis of coagulation factors
• Prolonged PT and aPTT
• May have thrombocytopenia due to hypersplenism

Disseminated Intravascular Coagulation (DIC):

• Consumption of coagulation factors and platelets
• Prolonged PT, aPTT, decreased fibrinogen, elevated D-dimer
• Causes: Sepsis, malignancy, obstetric complications

Hematologic Malignancies

Hematologic malignancies require understanding of classification systems, staging, and treatment approaches. These conditions often present with nonspecific symptoms, making diagnostic skills crucial for PANCE success.

Leukemias

Acute Lymphoblastic Leukemia (ALL):

• Most common childhood leukemia
• Lymphoblasts on peripheral smear
• Philadelphia chromosome positive in 25% of adult cases
• Treatment: Intensive chemotherapy, stem cell transplant

Acute Myeloid Leukemia (AML):

• Most common acute leukemia in adults
• Myeloblasts with Auer rods (pathognomonic)
• Associated with prior chemotherapy or radiation
• Treatment: Induction and consolidation chemotherapy

Chronic Lymphocytic Leukemia (CLL):

• Most common leukemia in Western adults
• Mature-appearing lymphocytes, smudge cells
• Asymptomatic in early stages
• Treatment: Watch and wait, rituximab-based regimens

Chronic Myeloid Leukemia (CML):

• Philadelphia chromosome (t(9;22)) in >95% of cases
• Three phases: chronic, accelerated, blast crisis
• Treatment: Tyrosine kinase inhibitors (imatinib)

Lymphomas

Hodgkin Lymphoma:

• Reed-Sternberg cells pathognomonic
• Contiguous spread pattern
• B-symptoms: fever, night sweats, weight loss
• Excellent prognosis with treatment

Non-Hodgkin Lymphoma:

• More common than Hodgkin lymphoma
• Non-contiguous spread
• Various subtypes with different prognoses
• Treatment varies by subtype and stage

White Blood Cell Disorders

White blood cell disorders encompass both quantitative and qualitative abnormalities. Understanding normal WBC differential counts and causes of abnormalities is essential for clinical practice and PANCE success.

Neutrophil Disorders

Neutrophilia (>7,700/μL):

• Bacterial infections
• Tissue necrosis (burns, myocardial infarction)
• Medications (corticosteroids, lithium)
• Malignancy
• Stress response

Neutropenia (<1,800/μL):

• Viral infections
• Chemotherapy and radiation
• Autoimmune disorders
• B12/folate deficiency
• Hypersplenism

Severe Neutropenia (<500/μL):

• High infection risk
• Requires protective isolation
• Consider G-CSF therapy
• Monitor for fever and signs of infection

Lymphocyte Disorders

Lymphocytosis:

• Viral infections (EBV, CMV, pertussis)
• Chronic lymphocytic leukemia
• Lymphoma
• Autoimmune disorders

Lymphocytopenia:

• HIV infection
• Corticosteroid therapy
• Chemotherapy
• Systemic lupus erythematosus
• Severe stress

Essential Laboratory Values

Mastering normal laboratory values and understanding their clinical significance is crucial for success in Domain 7. The practice questions frequently test the ability to interpret laboratory results within clinical contexts.

Laboratory Test	Normal Range	Clinical Significance
Hemoglobin (Male)	13.5-17.5 g/dL	Oxygen-carrying capacity
Hemoglobin (Female)	12.0-15.5 g/dL	Oxygen-carrying capacity
Hematocrit (Male)	41-53%	Percentage of blood volume occupied by RBCs
Hematocrit (Female)	36-46%	Percentage of blood volume occupied by RBCs
MCV	80-100 fL	Average RBC size
MCH	27-32 pg	Average hemoglobin per RBC
MCHC	32-36 g/dL	Hemoglobin concentration in RBCs
Platelet Count	150,000-400,000/μL	Primary hemostasis
WBC Count	4,500-11,000/μL	Immune function and infection response
Reticulocyte Count	0.5-2.5%	Bone marrow RBC production

Iron Studies

Test	Iron Deficiency	Anemia of Chronic Disease	Hemochromatosis
Serum Iron	Low	Low	High
TIBC	High	Low	Low
Ferritin	Low	Normal/High	Very High
Iron Saturation	Low (<16%)	Low	High (>45%)

Study Strategies for Domain 7

Effective preparation for Domain 7 requires a systematic approach that integrates factual knowledge with clinical reasoning skills. Based on the 91.5% first-time pass rate data, successful candidates focus on high-yield topics and practice application-based questions.

Recommended Study Approach

Phase 1: Foundation Building (2-3 weeks)

• Review basic hematology physiology and terminology
• Study normal laboratory values and reference ranges
• Learn classification systems for anemias and malignancies
• Create concept maps connecting related disorders

Phase 2: Clinical Integration (3-4 weeks)

• Practice case-based scenarios and patient presentations
• Focus on laboratory interpretation within clinical contexts
• Study treatment algorithms and medication mechanisms
• Review interactions with other organ systems

Phase 3: Question Practice and Review (2-3 weeks)

• Complete domain-specific practice questions
• Analyze incorrect answers and knowledge gaps
• Review high-yield topics identified through practice
• Simulate exam conditions with timed question blocks

Sample Questions and Explanations

Understanding the format and reasoning behind PANCE questions helps improve performance across all domains. These examples demonstrate the clinical reasoning skills tested in Domain 7.

Sample Question 1: Anemia Classification

Question: A 45-year-old woman presents with fatigue and weakness. Laboratory studies show Hgb 8.2 g/dL, MCV 72 fL, ferritin 8 ng/mL, and TIBC 420 μg/dL. What is the most likely diagnosis?

A) Anemia of chronic disease
B) Iron deficiency anemia
C) Thalassemia minor
D) Sideroblastic anemia

Correct Answer: B) Iron deficiency anemia

Explanation: The combination of microcytic anemia (MCV 72 fL), low ferritin (8 ng/mL), and elevated TIBC (420 μg/dL) is classic for iron deficiency anemia. Anemia of chronic disease would show normal-to-elevated ferritin and low TIBC. Thalassemia minor typically has normal iron studies, and sideroblastic anemia would show elevated iron stores.

Sample Question 2: Coagulation Disorders

Question: A 28-year-old male presents with spontaneous knee swelling and prolonged bleeding after dental extraction. His aPTT is 68 seconds (normal 25-35), and PT is 12 seconds (normal 11-13). Factor VIII activity is 3% (normal 50-150%). What is the most appropriate initial treatment?

A) Fresh frozen plasma
B) Cryoprecipitate
C) Factor VIII concentrate
D) Desmopressin

Correct Answer: C) Factor VIII concentrate

Explanation: This patient has severe Hemophilia A (Factor VIII deficiency <1% is severe, 1-5% is moderate). The prolonged aPTT with normal PT, joint bleeding (hemarthroses), and very low Factor VIII activity confirm the diagnosis. Factor VIII concentrate provides specific factor replacement and is the treatment of choice for severe deficiency.

Test-Taking Tips for Domain 7

Success on hematologic system questions requires specific test-taking strategies that account for the clinical reasoning emphasis of the PANCE examination.

Laboratory Interpretation Strategy

• Start with the CBC: Use MCV to classify anemias before considering other laboratory values
• Look for patterns: Multiple abnormal values often point to specific diagnoses
• Consider clinical context: Laboratory abnormalities must fit the patient presentation
• Think pathophysiology: Understanding mechanisms helps differentiate similar conditions

Common Question Types

Diagnostic Questions:

• Present patient symptoms with laboratory findings
• Require integration of multiple data points
• Often include distractors with similar presentations
• Focus on distinguishing features of each condition

Treatment Questions:

• Test knowledge of appropriate therapeutic interventions
• May include medication mechanisms and contraindications
• Consider both acute management and long-term care
• Account for patient-specific factors

Laboratory Questions:

• Test interpretation of specific laboratory patterns
• Require knowledge of normal reference ranges
• May present progressive laboratory changes
• Focus on clinical significance of abnormal values

Remember that the PANCE difficulty comes not from obscure facts but from the need to apply knowledge in clinical scenarios. Focus on understanding relationships between laboratory findings and patient presentations rather than memorizing isolated values.